Mobile Prenatal App Shown to Reduce in-Person Visits During Pregnancy

Using the mobile app Babyscripts reduced in-person prenatal care visits while maintaining patient and provider satisfaction, according to research published in JMIR mHealth and uHealth by physician researchers from the George Washington University (GW).

"Prenatal care is one of the most widely utilized preventative health care services, however there is little research on the effectiveness of standard prenatal care," said Kathryn Marko, MD, first author of the paper and assistant professor of obstetrics and gynecology at the GW School of Medicine and Health Sciences. "We wanted to reevaluate the model for low-risk pregnancies and see if a mobile prenatal app could remove barriers to access and reduce the burden on patients and the health care system."

Mobile health apps have the potential to transform health care. Studies have shown mobile technology can improve disease management for diabetes self-care activities, HIV infection medication adherence, and sickle cell anemia medication adherence. The research team, led by Marko, hypothesized that mobile health apps could be just as transformative for prenatal care.

The Babyscripts app was built to deliver educational content and remotely monitor blood pressure and weight. The app gave patients information on topics like nutrition and breastfeeding, but also gave patients and providers early warnings about hypertension or abnormal weight gain, which could indicate gestational diabetes, nutritional deficiency, or edema associated with preeclampsia.

Eligible participants were women between ages 18 - 40 years and considered low-risk - a singleton pregnancy with no previous diagnosis of hypertension, diabetes, renal disease, collagen vascular disease, maternal substance abuse, or other previously documented condition that could potentially lead to a poor pregnancy outcome. A total of 88 low-risk patients were enrolled in the study. Patients who used the app saw their OBGYN an average of 7.8 times. Patients who did not use the app saw their OBGYN an average of 10.2 times. There was no statistical difference in patient or provider satisfaction in either group.

"While the results of our study were largely positive, more research is needed to determine the connection between mobile prenatal apps and maternal or fetal outcomes," said Andrew Meltzer, MD, co-author of the paper and associate professor of emergency medicine at the GW School of Medicine and Health Sciences. "There is a lot more potential for use of mobile prenatal apps for both patients and providers."

Marko KI, Ganju N, Krapf JM, Gaba ND, Brown JA, Benham JJ, Oh J, Richards LM, Meltzer AC.
A Mobile Prenatal Care App to Reduce In-Person Visits: Prospective Controlled Trial.
JMIR Mhealth Uhealth 2019;7(5):e10520. doi: 10.2196/10520.

Most Popular Now

Derby Starts Drive for Safer and more In…

DXC Technology (NYSE: DXC) is collaborating with Royal Derby Hospital, part of the University Hospitals of Derby and Burton NHS Foundation Trust, on an initiative that will better alert doctors...

What the Radiologist should Know about A…

This paper aims to provide a review of the basis for application of AI in radiology, to discuss the immediate ethical and professional impact in radiology, and to consider possible...

The Mobile Game that can Detect Alzheime…

A specially designed mobile phone game can detect people at risk of Alzheimer's - according to new research from the University of East Anglia. Researchers studied gaming data from an...

Hospital Diagnoses Critically Ill Childr…

The Rady Children’s Hospital (San Diego, USA) used Moon, software developed by the Leuven-based (Belgium) company Diploid. Moon is the first software worldwide to use Artificial Intelligence (AI) for the...

AstraZeneca Starts Artificial Intelligen…

AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic...

Novartis Presents First-of-its-Kind Algo…

Novartis today announced results from a validation study of the innovative, algorithm-based digital solution MS Progression Discussion Tool, or MSProDiscussTM. The tool aims to support and facilitate a discussion between...

Red Hat Helps Public Health England Use …

Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, announced that Public Health England (PHE), an executive agency of the Department of Health and Social Care...

Bayer Joins Sensyne Health Consortium Wo…

Sensyne Health plc (LSE: SENS), the British clinical AI technology company, and Bayer, the life sciences company, announce that Bayer has become Sensyne Health's preferred pharmaceutical partner to work together...